Filter
Disease Areas
Showing: 1 – 05 of 8 Product
Onivyde®
(irinotecan liposome injection)
Onivyde® is a registered trademark of Ipsen Biopharm Limited.
PATIENT SAFETY IS OUR TOP PRIORITY
We are committed to ensuring the continued safe and effective use of our medicines through the prompt detection, assessment, and communication of safety concerns.
REPORT AN ADVERSE EVENT (AE)
If you think you or someone you know has experienced an adverse event related to
an Ipsen product or has a product complaint, please contact Ipsen Biopharmaceuticals, Inc., at
+1 855 463 5127.
Adverse events may also be reported to the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
Request medical information
To request medical information on Ipsen’s US products, please visit: www.ipsenmedicalinformation.com/US
Alternatively, to request medical information, please contact us by – phone: 1-855-463-5127, fax: 1-866-681-1063.
©2024 Ipsen Biopharmaceuticals, Inc. MPSC-US-000006.